Duke Lupus Registry
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women.
The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
Systemic Lupus Erythematosus
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Duke Lupus Registry|
|Study Start Date:||July 2007|
|Estimated Primary Completion Date:||June 2017 (Final data collection date for primary outcome measure)|
The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the Duke Rheumatology clinic.
The Duke Lupus Registry has two main purposes:
- Improved patient care. By following disease activity scores and medication usage, we expect to improve our care of the patients seen in clinic.
- Future research on lupus outcomes. This may encompass a broad array of areas, including but not limited to cardiovascular health, pregnancy and fertility, infections, medication use, quality of life, and depression.
At each office visit, patients will complete a questionnaire, physicians will measure lupus activity, and patients may be asked to provide a small blood sample. Patients will not be required to make extra visits to Duke in order to participate -- all paperwork and blood draws will occur during a regularly scheduled office visit with the physician.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00512694
|Contact: Martin Tochacek, PhD||(919) firstname.lastname@example.org|
|United States, North Carolina|
|Duke University Medical Center||Recruiting|
|Durham, North Carolina, United States, 27710|
|Contact: Martin Tochacek, PhD|
|Sub-Investigator: Stacy Ardoin, MD|
|Sub-Investigator: Lisa G. Criscione-Schreiber, MD|
|Principal Investigator: Megan E. B. Clowse, MD, MPH|
|Principal Investigator:||Megan E. B. Clowse, MD, MPH||Duke University|